Provided by Tiger Trade Technology Pte. Ltd.

Regenxbio

7.60
+0.14501.95%
Post-market: 7.59-0.0050-0.07%16:15 EDT
Volume:1.00M
Turnover:7.62M
Market Cap:501.37M
PE:-2.02
High:7.73
Open:7.31
Low:7.20
Close:7.45
52wk High:16.19
52wk Low:5.46
Shares:66.01M
Float Shares:57.34M
Volume Ratio:0.62
T/O Rate:1.75%
Dividend:- -
Dividend Rate:- -
EPS(TTM):-3.7652
EPS(LYR):-3.7593
ROE:-137.63%
ROA:-21.20%
PB:6.99
PE(LYR):-2.02

Loading ...

Mizuho Initiates REGENXBIO at Outperform With $22 Price Target

MT Newswires Live
·
Oct 05

Analysts Are Bullish on Top Healthcare Stocks: RegenXBio (RGNX), Benitec Biopharma (BNTC)

TIPRANKS
·
Sep 28

Analysts Offer Insights on Healthcare Companies: RegenXBio (RGNX) and Resmed (RMD)

TIPRANKS
·
Sep 25

Regenxbio presents positive 3-year durability data for Surabgene Lomparvove

TIPRANKS
·
Sep 25

Regenxbio Reports 3-Year Durability Data for Sura-Vec in Phase II Altitude Diabetic Retinopathy Trial

Reuters
·
Sep 25

Regenxbio Says Sarepta to Pay $39 Million to Regenxbio Within 10 Days of Effective Date

Reuters
·
Sep 24

Regenxbio - Sarepta to Pay $39 Mln to Regenxbio Within 10 Days of Effective Date - SEC Filing

THOMSON REUTERS
·
Sep 24

Regenxbio - All Ongoing Patent Litigation Regarding Patents-in-Suit to be Terminated with Prejudice - SEC Filing

THOMSON REUTERS
·
Sep 24

Regenxbio - Agrees not to Sue Sarepta or Affiliates over Existing Elevidys or Aavrh74-Based Capsids - SEC Filing

THOMSON REUTERS
·
Sep 24

Regenxbio Inc: Co and Trustees of University of Pennsylvania Entered into Settlement Agreement with Sarepta Therapeutics Inc

THOMSON REUTERS
·
Sep 24

Regenxbio Settles Sarepta Patent Litigation over Elevidys for USD 39 Million

Reuters
·
Sep 24

Bank of America Securities Keeps Their Buy Rating on RegenXBio (RGNX)

TIPRANKS
·
Sep 21

Regenxbio to Join Baird, Morgan Stanley Healthcare Investor Conferences

Reuters
·
Sep 08

Top Premarket Gainers

MT Newswires Live
·
Aug 28

Regenxbio Climbs as New Director Buys Nearly $1 Million of Stock

Reuters
·
Aug 28

Regenxbio director buys $949.4K in common stock

TIPRANKS
·
Aug 28

Regenxbio Director Gregory Austin Ciongoli Acquires Common Shares Worth $952,001.59

Reuters
·
Aug 28

Regenxbio Director Gregory Austin Ciongoli Files Initial Beneficial Ownership Statement

Reuters
·
Aug 28

Regenxbio Inc. : H.c. Wainwright Cuts Target Price to $21 from $23

THOMSON REUTERS
·
Aug 25

Regenxbio Appoints Greg Ciongoli to Board of Directors

Reuters
·
Aug 25